Medicus Pharma (MDCX) Other Non Operating Income (2024 - 2025)
Medicus Pharma (MDCX) posted Other Non Operating Income of -$25000.0 for Q3 2025, up 84.37% quarter-over-quarter from -$159996.0 in Q2 2025, and down 145.03% year-on-year from $55514.0 in Q3 2024.
Medicus Pharma (MDCX) Other Non Operating Income (2024 - 2025) Analysis & Trends
Medicus Pharma (MDCX) has reported Other Non Operating Income for 2 consecutive years, with -$25000.0 the latest figure, recorded in Q3 2025.
- Other Non Operating Income for Q3 2025 came in at -$25000.0, down 145.03% year-over-year; the trailing twelve-month figure through Dec 2025 was -$161130.0 (down 585.34% YoY), and the FY2025 annual result was -$25000.0, changed N/A from the prior year.
- Other Non Operating Income was -$25000.0 for Q3 2025 at Medicus Pharma, up from -$159996.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $55514.0 in Q3 2024 and troughed at -$159996.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Medicus Pharma | 6.91 Mn | -1.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -25,000.00 |
| Jun 30, 2025 | -159,996.00 |
| Mar 31, 2025 | 23,866.00 |
| Sep 30, 2024 | 55,514.00 |
| Jun 30, 2024 | -79,025.00 |